A citation-based method for searching scientific literature

John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
Times Cited: 348







List of co-cited articles
673 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
Aino Latva-Rasku, Miikka-Juhani Honka, Joel Kullberg, Nina Mononen, Terho Lehtimäki, Juha Saltevo, Anna K Kirjavainen, Virva Saunavaara, Patricia Iozzo, Lars Johansson,[...]. Diabetes Care 2019
59
5

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Jeffrey Cui, Len Philo, Phirum Nguyen, Heather Hofflich, Carolyn Hernandez, Ricki Bettencourt, Lisa Richards, Joanie Salotti, Archana Bhatt, Jonathan Hooker,[...]. J Hepatol 2016
182
3

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Yosuke Okada, Takamasa Ichijo, Mariko Higa, Toru Hiyoshi, Ikuo Inoue, Kaoru Iso, Hidenori Yoshii,[...]. Cardiovasc Diabetol 2020
32
9


Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.
Jianhong Zhu, Xiaoxia Yu, Yayuan Zheng, Jianfang Li, Yong Wang, Yin Lin, Zhichao He, Wenxia Zhao, Chuxiong Chen, Kaifeng Qiu,[...]. Lancet Diabetes Endocrinol 2020
33
9

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Adriaan Kooy, Jolien de Jager, Philippe Lehert, Daniël Bets, Michiel G Wulffelé, Ab J M Donker, Coen D A Stehouwer. Arch Intern Med 2009
249
3

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Rémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, Nadir Kellou, Michel Cucherat, Jean-Pierre Boissel, Behrouz Kassai, Alain Moreau, François Gueyffier, Catherine Cornu. PLoS Med 2012
155
3


Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study.
Mario Luca Morieri, Mauro Rigato, Vera Frison, Natalino Simioni, Michele D'Ambrosio, Federica Tadiotto, Agostino Paccagnella, Annunziata Lapolla, Angelo Avogaro, Gian Paolo Fadini. Diabetes Obes Metab 2019
12
16

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Richard E Pratley, Roy Eldor, Annaswamy Raji, Gregory Golm, Susan B Huyck, Yanping Qiu, Sheila Sunga, Jeremy Johnson, Steven G Terra, James P Mancuso,[...]. Diabetes Obes Metab 2018
87
2

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.
Lawrence Blonde, Kamlesh Khunti, Stewart B Harris, Casey Meizinger, Neil S Skolnik. Adv Ther 2018
141
2

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
2

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study.
Russell Scott, Jerry Morgan, Zachary Zimmer, Raymond L H Lam, Edward A O'Neill, Keith D Kaufman, Samuel S Engel, Annaswamy Raji. Diabetes Obes Metab 2018
16
12

Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J Woerle, Uli C Broedl. Diabetes Care 2015
201
2

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.
Goodarz Danaei, Mariel M Finucane, Yuan Lu, Gitanjali M Singh, Melanie J Cowan, Christopher J Paciorek, John K Lin, Farshad Farzadfar, Young-Ho Khang, Gretchen A Stevens,[...]. Lancet 2011
2

Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Paraskevi Salpea, Suvi Karuranga, Inga Petersohn, Belma Malanda, Edward W Gregg, Nigel Unwin, Sarah H Wild, Rhys Williams. Diabetes Res Clin Pract 2020
92
2

Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.
Mahesh M Umapathysivam, Michael Y Lee, Karen L Jones, Christopher E Annink, Caroline E Cousins, Laurence G Trahair, Chris K Rayner, Marianne J Chapman, Michael A Nauck, Michael Horowitz,[...]. Diabetes 2014
79
2

Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Rhys Williams, Suvi Karuranga, Belma Malanda, Pouya Saeedi, Abdul Basit, Stéphane Besançon, Christian Bommer, Alireza Esteghamati, Katherine Ogurtsova, Ping Zhang,[...]. Diabetes Res Clin Pract 2020
107
2


Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Johanna Helmstädter, Katie Frenis, Konstantina Filippou, Alexandra Grill, Mobin Dib, Sanela Kalinovic, Franziska Pawelke, Kamil Kus, Swenja Kröller-Schön, Matthias Oelze,[...]. Arterioscler Thromb Vasc Biol 2020
42
4

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.
Martin Ridderstråle, Knut Robert Andersen, Cordula Zeller, Gabriel Kim, Hans J Woerle, Uli C Broedl. Lancet Diabetes Endocrinol 2014
234
2

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
723
2


Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky,[...]. N Engl J Med 2013
630
2

Active sugar transport in health and disease.
E M Wright, B A Hirayama, D F Loo. J Intern Med 2007
401
2

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
2

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
95
2


Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
George L Bakris, Rajiv Agarwal, Juliana C Chan, Mark E Cooper, Ron T Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E Schmieder, Christina Nowack,[...]. JAMA 2015
284
2


Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
David Z I Cherney, Bernard Zinman, Silvio E Inzucchi, Audrey Koitka-Weber, Michaela Mattheus, Maximilian von Eynatten, Christoph Wanner. Lancet Diabetes Endocrinol 2017
185
2

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Rajiv Saran, Bruce Robinson, Kevin C Abbott, Lawrence Y C Agodoa, Jennifer Bragg-Gresham, Rajesh Balkrishnan, Nicole Bhave, Xue Dietrich, Zhechen Ding, Paul W Eggers,[...]. Am J Kidney Dis 2019
391
2

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.
R A DeFronzo, J A Davidson, S Del Prato. Diabetes Obes Metab 2012
322
2

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Pantelis Sarafidis, Charles J Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque,[...]. Nephrol Dial Transplant 2019
76
2

Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.
Yoon-Kyung Chang, Hyunsu Choi, Jin Young Jeong, Ki-Ryang Na, Kang Wook Lee, Beom Jin Lim, Dae Eun Choi. PLoS One 2016
67
2


Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
146
2


Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.
Minh Tuan Nguyen, Isabelle Pham, Paul Valensi, Hélène Rousseau, Eric Vicaut, Christelle Laguillier-Morizot, Alain Nitenberg, Emmanuel Cosson. Cardiovasc Diabetol 2014
10
20

Cardiac dual-source CT for the preoperative assessment of patients undergoing bariatric surgery.
A Tognolini, C S Arellano, W Marfori, J W Sayre, J L Hollada, J G Goldin, E P Dutson, S G Ruehm. Clin Radiol 2013
3
66

Subclinical coronary atherosclerosis identified by coronary computed tomographic angiography in asymptomatic morbidly obese patients.
Martin S Lubanski, Thomas E Vanhecke, Kavitha M Chinnaiyan, Barry A Franklin, Peter A McCullough. Heart Int 2010
7
28

Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus.
David J Holland, Thomas H Marwick, Brian A Haluska, Rodel Leano, Matthew D Hordern, James L Hare, Zhi You Fang, Johannes B Prins, Tony Stanton. Heart 2015
85
2

Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?
A-L Borel, R Tamisier, P Böhme, P Priou, A Avignon, P-Y Benhamou, H Hanaire, J-L Pépin, L Kessler, P Valensi,[...]. Diabetes Metab 2019
10
20

The prognostic value of T wave amplitude in lead aVR in males.
Swee Y Tan, Gregory Engel, Jonathan Myers, Marcus Sandri, Victor F Froelicher. Ann Noninvasive Electrocardiol 2008
43
4

Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.
Laura Bierhansl, Lena-Christin Conradi, Lucas Treps, Mieke Dewerchin, Peter Carmeliet. Physiology (Bethesda) 2017
39
5

Coronary artery disease in patients with chronic kidney disease: a clinical update.
Qiangjun Cai, Venkata K Mukku, Masood Ahmad. Curr Cardiol Rev 2013
86
2

Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.
Erik B Schelbert, Jie J Cao, Sigurdur Sigurdsson, Thor Aspelund, Peter Kellman, Anthony H Aletras, Christopher K Dyke, Gudmundur Thorgeirsson, Gudny Eiriksdottir, Lenore J Launer,[...]. JAMA 2012
189
2

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?
E Cosson, F Paycha, J Paries, S Cattan, A Ramadan, D Meddah, J-R Attali, P Valensi. Diabet Med 2004
44
4

Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia.
S Sejil, B Janand-Delenne, J-F Avierinos, G Habib, N Labastie, D Raccah, P Vague, V Lassmann-Vague. Diabet Med 2006
7
28

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
John B Buse, Henry N Ginsberg, George L Bakris, Nathaniel G Clark, Fernando Costa, Robert Eckel, Vivian Fonseca, Hertzel C Gerstein, Scott Grundy, Richard W Nesto,[...]. Diabetes Care 2007
364
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.